Frontiers | Public Immunity: Evolutionary Spandrels for Pathway-Amplifying Protective Antibodies
Multiple roles for HIV broadly neutralizing antibodies | Science Translational Medicine
LIBRA-seq: Accelerating antibody discovery
Exploiting a chink in the armor: engineering broadly neutralizing monoclonal antibodies for SARS-like viruses | Signal Transduction and Targeted Therapy
Recombinant Mouse IgG Antibody
Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2
Human inhalable antibody fragments neutralizing SARS-CoV-2 variants for COVID-19 therapy: Molecular Therapy
Non-neutralizing antibodies and vaccine-induced protection against HIV | Future HIV Therapy
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection - ScienceDirect
What is antibody therapy?
SARS-CoV-2 Neutralizing Antibodies | Sino Biological
Peptide Blocking: Novus Biologicals
SARS CoV-2 Neutralizing Antibody Detection Kit | GenScript
Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome | Science Immunology
SARS-CoV-2 Neutralization Antibody Detection Kit | MBL Life Sience -ASIA-
Anti-mCD25 | PC-61.5.3 & 7D4| InvivoGen
Frontiers | Validation of a Triplex Pharmacokinetic Assay for Simultaneous Quantitation of HIV-1 Broadly Neutralizing Antibodies PGT121, PGDM1400, and VRC07-523-LS
COVID-19 Neutralizing Antibody Test Kit - JOYSBIO Biotechnology
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses: Trends in Immunology
Passive antibody therapy in COVID-19 | Nature Reviews Immunology
Anti-IL-33 neutralizing monoclonal antibody | InvivoGen
Anta", "Block", "Neutra"...but Who Are They? - Innovative antibodies against haptens and transmembrane proteins
A Multifunctional Neutralizing Antibody‐Conjugated Nanoparticle Inhibits and Inactivates SARS‐CoV‐2 - Cai - 2022 - Advanced Science - Wiley Online Library
Treatment of mice with a ligand binding blocking anti-CD28 monoclonal antibody improves healing after myocardial infarction | PLOS ONE
